Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2020

Sep 12, 2020

30198_dirs_2020-09-11_4e6a1e9b-49d2-486d-9839-d84848582d33.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-09-09

Reporting Person: Selvaraj Shelly Ramasamy (SVP Information Technology)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-09-09 Common Stock S 1236 $398.302 Disposed 20845 Direct
2020-09-09 Common Stock S 281 $398.302 Disposed 20564 Direct
2020-09-09 Common Stock S 709 $398.302 Disposed 19855 Direct
2020-09-10 Common Stock S 1000 $399.5972 Disposed 18855 Direct
2020-09-10 Common Stock S 207 $400.1935 Disposed 18648 Direct
2020-09-10 Common Stock S 856 $401.7392 Disposed 17792 Direct
2020-09-10 Common Stock S 10 $402.38 Disposed 17782 Direct
2020-09-10 Common Stock S 29 $405.33 Disposed 17753 Direct

Footnotes

F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2: Included in this number are 12,568 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 4,134 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 2,951 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

F3: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F4: This transaction was executed in multiple trades at prices ranging from $399.116 to $399.98. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F5: This transaction was executed in multiple trades at prices ranging from $400.15 to $400.24. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F6: This transaction was executed in multiple trades at prices ranging from $401.37 to $402.33. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.